Activation of several signaling pathways, including PI3K/Akt, MAPK, JAK-STAT, and NF-κB has also been reported in T-ALL (reviewed by Cardoso et al. [64] and Staal and Langerak [65]). This evidence concerns the gene NFKB1 and acute lymphoblastic leukemia.